Dr Marjan Golgasmi

Founder, Anchoris Pharma Limited

Pharm.D. | Pharmaceutical Scientist | Medical Affairs & Scientific Communications

Dr Marjan Golgasmi is the founder of Anchoris Pharma Limited, a UK-based pharmaceutical consultancy created to support healthcare, pharmaceutical, medical affairs, and medical communications teams with scientifically rigorous, strategically useful, and visually clear medical content.

A Doctor of Pharmacy graduate with a multidisciplinary background across pharmaceutical science, pharmacy practice, scientific writing, medical representation, quality control, regulatory exposure, and evidence-based communication, Marjan brings a rare combination of scientific depth, clinical understanding, commercial awareness, and creative communication to her work.

Her professional journey began with a deep curiosity about medicines: not only how they are prescribed or dispensed, but how they work, how they are studied, how evidence is generated, how healthcare professionals interpret data, and how complex scientific information can be translated into communication that is accurate, useful, and human.

For Marjan, pharmaceutical science has never been limited to one setting. It sits at the intersection of chemistry, biology, clinical decision-making, patient experience, regulation, communication, and commercial reality. This perspective has shaped the foundation of Anchoris Pharma Limited: a company built to help organisations transform complex evidence into clear, compliant, strategically aligned medical communication.

Marjan trained as a Doctor of Pharmacy and developed early experience across scientific research, pharmaceutical analysis, manuscript preparation, technical editing, pharmacy practice, and industry-facing communication. Her work has included exposure to pharmaceutical analysis and method development, HPLC-based research, quality control, scientific and editorial contribution, community pharmacy, oncology and specialty medicines communication, healthcare professional engagement, and regulatory inspection-related activity.

This breadth of experience has given her a practical understanding of how medicines move from scientific concept to clinical use: from laboratory thinking and data interpretation to pharmacy operations, HCP conversations, medical messaging, evidence communication, and the standards required in regulated healthcare environments.

Marjan’s scientific interests are broad, but deeply connected by one theme: complexity. She is drawn to therapy areas and scientific questions where the evidence is nuanced, the mechanisms are intricate, and the communication challenge is meaningful. Her interests include neurodegenerative disease, Alzheimer’s disease, oncology, psychopharmacology, antipsychotic medicines, drug delivery systems, pharmaceutical analysis, real-world evidence, data interpretation, clinical trial design, and the evolving role of artificial intelligence in healthcare.

She is particularly interested in the space between scientific evidence and human understanding. In medical affairs and scientific communications, the challenge is not simply to present data. The challenge is to make evidence usable without oversimplifying it, to communicate clearly without losing nuance, and to create content that respects both the science and the audience.

That principle sits at the heart of Anchoris.

Marjan believes medical content should do more than look polished. It should have a purpose. It should help people think more clearly. It should support better scientific discussions. It should make complex evidence easier to navigate. It should be accurate, balanced, compliant, and relevant to real healthcare decisions.

Her approach combines scientific rigour with strategic communication. She is interested in how evidence is framed, how messages are structured, how data are visualised, how healthcare professionals engage with information, and how medical materials can be made more useful in the real world.

Before founding Anchoris Pharma Limited, Marjan built experience across multiple areas of pharmacy and pharmaceutical science. Her background includes Doctor of Pharmacy training, pharmaceutical research, scientific writing, technical editing, pharmacy practice, medical representation, oncology and specialty medicines communication, HCP and KOL engagement, quality control, and regulatory inspection exposure. This combination allows her to view medical communication not as isolated writing, but as part of a wider scientific, clinical, operational, and commercial ecosystem.

Her pharmacy background gives her a strong respect for clinical accuracy, patient safety, and the practical realities of healthcare delivery. Her research and pharmaceutical analysis experience give her a structured approach to evidence, methodology, and data interpretation. Her editorial and scientific writing experience shape her attention to clarity, precision, and structure. Her industry-facing experience informs her understanding of stakeholder needs, strategic messaging, and the importance of compliant, balanced communication.

Through Anchoris, Marjan supports the development of medical affairs and scientific communications deliverables that are designed to be clear, credible, and useful. This may include evidence summaries, medical decks, disease area materials, HCP-facing scientific content, internal training materials, scientific narratives, congress-related content, advisory board materials, literature-based outputs, and portfolio pieces that help teams communicate complex science with confidence.

Her standards are deliberately high. Every piece of work should be scientifically defensible, strategically relevant, visually considered, and appropriate for its audience. She values accuracy, compliance awareness, logical structure, clear messaging, and respect for healthcare professionals’ time.

Marjan is also interested in the future of medical communication: how scientific content can become more engaging without becoming promotional, how visual storytelling can improve understanding, how artificial intelligence can support evidence synthesis and content development responsibly, and how medical affairs teams can create materials that feel more alive while remaining compliant and scientifically grounded.

She believes the best medical communication sits between discipline and creativity. It requires scientific accuracy, but also judgement. It requires compliance, but also imagination. It requires strategic thinking, but also humility in front of the evidence.

Anchoris Pharma Limited was created from this philosophy.

The name Anchoris reflects a sense of anchoring: anchoring communication in evidence, anchoring strategy in science, and anchoring complex information in clarity. In a healthcare environment where scientific information is expanding rapidly, Anchoris exists to help teams create work that is not only accurate, but usable, structured, and memorable.

Marjan’s objective is to build Anchoris into a trusted boutique partner for pharmaceutical, healthcare, and medical communications teams who need high-quality scientific content with both rigour and originality. Her aim is to support projects where evidence needs to be understood, shaped, communicated, and translated into meaningful professional dialogue.

At the centre of her work is a simple belief: good medical communication should not dilute science. It should reveal it.

It should make the logic of the evidence visible. It should help healthcare professionals see the relevance of data. It should support better scientific exchange. It should connect mechanism, evidence, clinical context, and real-world value.

Marjan’s work is guided by five core principles:

Scientific rigour — content should be grounded in evidence, accurately interpreted, and carefully referenced.

Strategic relevance — communication should serve a clear purpose and support meaningful scientific or medical objectives.

Compliance awareness — materials should respect the boundaries of regulated healthcare communication.

Clarity and structure — complex information should be organised in a way that helps the audience understand, remember, and use it.

Evidence into impact — scientific content should not remain static; it should support better conversations, better decisions, and better understanding.

Through Anchoris Pharma Limited, Marjan brings together her background in pharmacy, pharmaceutical science, medical affairs thinking, and scientific communication to help transform complex evidence into clear, compliant, strategically useful medical content.

Her mission is to create medical communication that feels intelligent, credible, and alive — content that respects the science, respects the audience, and supports the real work of healthcare.